Abstract: A particulate trap filter body has asymmetrical channels. The cross-sectional shape of the asymmetrical channel structure includes a combination of hexagonal, square and triangular shapes. The hexagonal channel and the triangular channel act as inlet channel, and the square channel acts as outlet channel. Compared with the traditional symmetrical filter body structure, the inlet channel volume and filter body wall area can be effectively increased by more than 30%, which means that with capturing the same amount of particles, the particle cake layer formed on the wall surface is thinner. The limiting carbon load of the new channel structure is increased by more than 30%, having a very positive effect on reducing the regeneration frequency and prolonging the service life of the trap.

Abstract: A heat dissipation device with forced coolant flow is provided which includes a base, coolant conduits, and a driving module. The conduit includes an inlet port, an extension segment, and an outlet port. The extension segment is connected to the base. The driving module includes a housing, a separating member, and two magnetic driving members. The separating member, being a thin magnetic plate, is positioned in the housing and defines a first chamber and a second chamber for coolant. The first chamber and the second chamber are connected to the inlet port and the outlet port and a flow of coolant can be initiated by alternating an electrical current feed to the two magnetic driving members on each side of the separating member.

Abstract: A particulate trap filter body has asymmetrical channels. The cross-sectional shape of the asymmetrical channel structure includes a combination of hexagonal, square and triangular shapes. The hexagonal channel and the triangular channel act as inlet channel, and the square channel acts as outlet channel. Compared with the traditional symmetrical filter body structure, the inlet channel volume and filter body wall area can be effectively increased by more than 30%, which means that with capturing the same amount of particles, the particle cake layer formed on the wall surface is thinner. The limiting carbon load of the new channel structure is increased by more than 30%, having a very positive effect on reducing the regeneration frequency and prolonging the service life of the trap.

Abstract: A heat dissipation device with forced coolant flow is provided which includes a base, coolant conduits, and a driving module. The conduit includes an inlet port, an extension segment, and an outlet port. The extension segment is connected to the base. The driving module includes a housing, a separating member, and two magnetic driving members. The separating member, being a thin magnetic plate, is positioned in the housing and defines a first chamber and a second chamber for coolant. The first chamber and the second chamber are connected to the inlet port and the outlet port and a flow of coolant can be initiated by alternating an electrical current feed to the two magnetic driving members on each side of the separating member.

Abstract: A rotating socket comprises a wiring assembly, a rotating assembly, an elastic member, a locking mechanism, and a housing. The wiring assembly comprises a fixing base and lugs, the fixing base comprises a substrate and a side wall. The rotating assembly comprises a panel, a rotating base, conductive tabs and conductive rings. The locking mechanism controlling whether the rotating base is separated from the fixing base. When the locking mechanism is in a locked state, the rotating base compresses the elastic member, and one end of the rotating base away from the panel abuts against the substrate and is limited by the side wall; when the locking mechanism is in a unlocked state, the rotating base is separated from the fixed base by resilient force of the elastic member and free to be rotated.

Abstract: This invention relates to compounds, pharmaceutical compositions, and methods of using the disclosed compounds for inhibiting PARP.

Abstract: This invention relates to compounds, pharmaceutical compositions, and methods of using the disclosed compounds for inhibiting PARP.